The Department of Biomaterials at the University of Gothenburg and Chalmers have a long tradition of performing research on materials beneficial for people’s health. The research is considered to be world leading in several areas. It is driven in a multidisciplinary manner including theoretical modelling, novel synthesis procedures, state of the art characterisation techniques, and preclinical and clinical evaluation studies. A broad area of applications is covered such as tissue engineering, especially materials for osseointegration, materials for pharmaceuticals and personal care, and materials for food technologies. Moreover, the Department of Applied Physics has a long tradition in the development of analytical tools for measuring events at solid surfaces.
With the two VINN Excellence centres, BIOMATCELL and SuMo, with activities within the Wallenberg Wood Science Center, and with the strong attraction of national and international industrial partners, Chalmers and the University of Gothenburg provide the critical mass needed in order to be a major player in Europe for the development of the next generation of materials for medical devices. The centres together with external funding from organizations such as VR and Vinnova ensure that high quality competitive research is being performed. The research has a high scientific impact and has received a high international recognition.
These are the active fields within this profile area:
• Tissue and cell engineering
• Materials for pharmaceuticals and personal care
• Materials for biosensing
Examples of Excellence
Gothenburg is considered to be the birthplace of osseointegration (bone integration), largely due to the pioneering work by Professor Per-Ingvar Brånemark at the University of Gothenburg, who discovered the unique properties of titanium and its ability to attach directly to bone tissue. The discovery has resulted in millions of implant treatments, which has helped people with the restoration of missing body functions. The developed technique has also been commercially successful and companies such as Nobel Biocare, which has a significant market share in dental implants, has its foundation in this research. A more recent example on the theme of osseointegration, which has been developed at Chalmers, is the discovery that bone-like minerals can be formed using molecular self-assembly. These minerals have been shown to have remarkable biological properties and when deposited onto traditional titanium implants strongly reduces the healing time. The material has been commercialized by Promimic AB, a spin-off company from Chalmers, which through extensive pre-clinical evolutions together with the University of Gothenburg has reached the needed regulatory approvals for launching dental implants on the US market.